© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Ten years after combination HIV treatment was heralded as the one and only way to treat HIV, data are emerging to suggest that monotherapyR...
DHHS currently recommends either Sustiva® or Kaletra® for HIV-positive people starting treatment for the first time.
AIDSmeds Founder Peter Staley interviewed Dr. Joe Eron from the University of North Carolina in Chapel Hill and lead investigator of KLEAN.
AIDSmeds Founder Peter Staley interviewed Dr. Martin Markowitz of the Aaron Diamond AIDS Research Center.
Podcast coverage of the XVI International AIDS Conference in Toronto, Canada, August 13-18, 2006.
There’s always a lot of anticipation about the “late breaker” session, which presents research that wasn’t available until the last mi...
AIDSmeds Founder Peter Staley interviewed Dr. Donald Kotler, Chief of Gastroenterology at St. Luke’s-Roosevelt Hospital.
Encouraging results from a second study were reported today.
Forty-eight week results from a phase II clinical trial of TNX-355, an HIV-entry inhibitor, were reported today at the XVI International AIDS...
Preliminary results from an ongoing clinical trial of MK-0518, Merck’s experimental integrase inhibitor, suggest that it has comparable anti-H...
Final data from a 48-week study comparing Norvir (ritonavir)-boosted Lexiva (fosamprenavir) to Kaletra (ritonavir-boosted lopinavir).
Results from a clinical trial presented at the XVI International AIDS Conference (IAC) indicate that maraviroc, Pfizer’s experimental entry in...
The AIDS Clinical Trials Group has reported results from a clinical trial of vicriviroc, an experimental entry inhibitor being developed by Sc...
AIDSmeds Founder Peter Staley interviewed Dr. Anthony Fauci, Director of NIAID at the NIH, and head of AIDS research for U.S. government.
According to the World Health Organization (WHO), more than one million people in sub-Saharan Africa are currently receiving HIV treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
